comparemela.com

Latest Breaking News On - Biocon ltd - Page 3 : comparemela.com

Biocon signs licensing deal with Handok in South Korea - The Hindu BusinessLine

Biocon Limited partners with Handok Inc. for exclusive licensing of Synthetic Liraglutide in South Korea, targeting weight management market.

South koreaKyonggi doSouth koreanSiddharth mittalHandok incBiocon ltdBiocon limitedSynthetic liraglutideBarozen fitManaging director

Biocon Partners with Handok for Chronic Weight Management Drug

Biocon Partners with Handok for Chronic Weight Management Drug
indiainfoline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiainfoline.com Daily Mail and Mail on Sunday newspapers.

Kyonggi doSouth koreaSouth koreanSiddharth mittalYoungjin kimBiocon ltdManaging director siddharth mittalChairman youngjin kim

Indices: Stock market update: Nifty Pharma index falls 0 5%

Indices: Stock market update: Nifty Pharma index falls 0 5%
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Atal realtechIndian railway finAurobindo pharma ltdMankind pharma ltdBiocon ltdGlenmark pharmaceuticals ltdDivi laboratories ltdSanofi india ltdAbbott india ltdLupin ltdInox wind ltdTorrent pharmaceuticals ltdLaurus labs ltdNifty pharmaLaboratories ltdVodafone idea

Indices: Stock market update: Nifty Pharma index falls 0 52%

The Nifty Pharma index closed 0.52 per cent down at 19216.35.

Polyfab gujarAtal realtechElgi rubber coGland pharma ltdJb chemicals pharmaceuticals ltdNatco pharma ltdAlkem laboratories ltdBiocon ltdDivi laboratories ltdBrightcom groupLaurus labs ltdSuzlon energySun pharmaceutical industries ltdCochin shipyardLupin ltdIndian railway fin

Biocon Biologics secures USFDA approval for biosimilar product to treat ophthalmology conditions

The US Food and Drug Administration (USFDA) has approved the company s first-to-file application for Yesafili, a vascular endothelial growth factor inhibitor used to treat several different types of ophthalmology conditions, the company said in a statement.

United statesShreehas tambeBiocon biologicsDrug administrationBiocon ltdDirector shreehas tambe

vimarsana © 2020. All Rights Reserved.